Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 11, 1996, Pages 4051-4058

  Grinspoon, Steven ^a   Corcoran, Colleen ^a   Lee, Kristen ^a   Burrows, Belton ^b   Hubbard, Jane ^a   Katznelson, Laurence ^a   Walsh, Mark ^b   Guccione, Andrew ^a   Cannan, Jacqueline ^a   Heller, Howard ^a   Basgoz, Nesli ^a   Klibanski, Anne ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEGESTROL ACETATE; SOMATOMEDIN C; TESTOSTERONE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANDROGEN BLOOD LEVEL; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOGONADISM; ISOTOPE LABELING; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; MUSCLE ATROPHY; PRIORITY JOURNAL; TASK PERFORMANCE;

ADULT; ANDROGENS; APPETITE STIMULANTS; BODY COMPOSITION; DRUG RESISTANCE; EXERCISE; HIV WASTING SYNDROME; HUMAN GROWTH HORMONE; HUMANS; HYPOGONADISM; INSULIN-LIKE GROWTH FACTOR I; MALE; MEGESTROL ACETATE; MIDDLE AGED; MUSCLES; NUTRITIONAL STATUS; TESTOSTERONE; WEIGHT LOSS;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 10344231952     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.11.4051     Document Type: Article

References (54)

1. Kotler DP, Tierney AR, Wang J, Pierson Jr RN. 1989 Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr. 50:444-447.
2. Grinspoon SK, Bilezikian JB. 1992 HIV Disease and the endocrine System. N Engl J Med. 327:1360-1365.
3. Grunfeld C, Feingold KR. 1992 Metabolic disturbances and wasting in the acquired immunodeficiency syndrome. N Engl J Med. 327:329-337.
4. Lieberman SA, Butterfield GE, Harrison D, Hoffman AR. 1994 Anabolic effects of recombinant insulin-like growth factor-I in cachectic patients with the acquired immunodeficiency syndrome. J Clin Endocrinol Metab. 78:404-410.
5. Dobs AS, Dempsey MA, Ladenson PW, Polk BF. 1988 Endocrine disorders in men infected with human immunodeficiency virus. Am J Med. 84:611-616.
6. Croxson TS, Chapman WE, Miller LK, Levit CD, Senie R, Zumoff B. 1989 Changes in the hypothalamic-pituitary-gonadal axis in human immunodeficiency virus-infected homosexual men. J Clin Endocrinol Metab. 68:317-321.
7. Liu L, Merriam GR, Sherins RJ. 1987 Chronic sex steroid exposure increases mean plasma growth hormone concentration and pulse amplitude in men with isolated hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 64:651-656.
8. Weissberger AJ, Ho KK. 1993 Activation of the somatotropic axis by testosterone in adult males: evidence for the role of aromatization. J Clin Endocrinol Metab. 76:1407-1412.
9. Ulloa-Aguirre A, Blizzard RM, Garcia-Rubi E, et al. 1990 Testosterone and oxandrolone, a nonaromatizable androgen, specifically amplify the mass and rate of growth hormone (GH) secreted per burst without altering GH-secretory burst duration or frequency or the GH half-life. J Clin Endocrinol Metab. 71:846-854.
10. Bengtsson BA, Eden S, Lonn L, et al. 1993 Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab. 76:309-317.
11. Russell-Jones DL, Weissberger AJ, Bowes SB, et al. 1993 The effects of growth hormone on protein metabolism in adult growth hormone deficient patients. Clin Endocrinol (Oxf). 38:427-431.
12. Thompson JL, Butterfield GE, Marcus R, et al. 1995 The effects of recombinant human insulin-like growth factor-I and growth hormone on body composition in elderly women. J Clin Endocrinol Metab. 80:1845-1852.
13. Mauras N, Beaufrere B. 1995 Recombinant human insulin-like growth factor-I enhances whole body protein anabolism and significantly diminishes the protein catabolic effect of prednisone in humans without a diabetogenic effect. J Clin Endocrinol Metab. 80:869-874.
14. 1992 Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Normal reference laboratory values. N Engl J Med. 327:718-724.
15. 1983 Metropolitan height and weight tables. Stat Bull Metrop Insur Co. 64:2-9.
16. Mazess RB, Barden HS, Bisek JP, Hanson J. 1990 Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition. Am J Clin Nutr. 51:1106-1112.
17. Lukaski HC. 1987 Methods for the assessment of human body composition: traditional and new. Am J Clin Nutr. 46:537-556.
18. Roessler GS, Dunavant BG. 1967 Comparative evaluation of a whole-body counter potassium 40 method for measuring lean body mass. Am J Clin Nutr. 20:1171-1178.
19. Roubenoff R, Kehayias JJ. 1991 The meaning and measurement of lean body mass. Nutr Rev. 49:163-175.
20. Heymsfield SB, Tishe A, Zi-Mian W. 1994 Nutritional assessment by anthropometric and biochemical methods. In: Shils ME, Olson JA, Shike M, ed. Modern nutrition in health and disease. 1994, Philadelphia: Lea and Febiger; 829-834.
21. Spiekerman AM. 1993 Proteins used in nutritional assessment. Clin Lab Med. 13:353-369.
22. Heymsfield SB, Arteaga C, McMannus C, Smith J, Moffitt S. 1983 Measurement of muscle mass in humans: validity of the 24-hour urinary creatinine method. Am J Clin Nutr. 37:478-493.
23. Mendez J, Buskirk ER. 1971 Creatinine-height index. Am J Clin Nutr. 24:385-386.
24. Harris JA, Benedict FG. 1919 A biometric study of basal metabolism in man. Carnegie Institute of Washington.
25. Kohl HW, Blair SN, Paffenberger RS, Macera CA, Kronenfeld JJ. 1988 A mail survey of physical activity habits as related to measured physical fitness. Am J Epidemiol. 127:1228-1239.
26. Csuka M, McCarty DJ. 1984 Simple method for measurement of lower extremity muscle strength. Am J Med. 78:77-81.
27. Guyatt GH, Thompson PJ, Berman LB, et al. 1985 How should we measure function in patients with chronic heart and lung disease. J Chron Dis. 38:517-524.
28. Podsiadlo D, Richardson S. 1991 The timed "up and go": a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 39:142-148.
29. Cahalin L, Pappagianopoulos P, Prevost S, Wain J, Ginns L. 1995 The relationship of the 6-min walk test to maximal oxygen consumption in transplant candidates with end-stage lung disease. Chest. 108:452-459.
30. Rico H, Revila M, Villa LF, Ruiz-Contreras D, Hernandez ER, Alvarez de Buergo M. 1994 The four-compartment models in body composition: data from a study with dual-energy x-ray absorptiometry and near-infrared interactance on 815 normal subjects. Metabolism. 43:417-422.
31. Blackburn GL, Bistrian BR, Maini BS, Schlamm HT, Smith MF. 1977 Nutritional and metabolic assessment of the hospitalized patient. JPEN J Parenter Nutr. 1:11-22.
32. Kotler DP, Wang J, Pierson RN. 1985 Body composition studies in patients with the acquired immunodeficiency syndrome. Am J Clin Nutr. 42:1255-1265.
33. Christeff N, Gharakhanian S, Thobie N, Rozenbaum W, Nunez E. 1992 Evidence for changes in adrenal and testicular steroids during HIV infection. J Acquir Immune Defic Syndr. 5:841-846.
34. Merenich JA, McDermott MT, Asp AA, Harrison SM, Kidd GS. 1990 Evidence of endocrine involvement early in the course of human immunodeficiency virus infection. J Clin Endocrinol Metab. 70:566-571.
35. Raffi F, Brisseau JM, Planchon B, Remi JP, Barrier JH, Grolleau JY. 1991 Endocrine function in 98 HIV-infected patients: a prospective study. AIDS. 5:729-733.
36. Villette JM, Bourin P, Doinel C, et al. 1990 Circadian variations in plasma levels of hypophyseal, adrenocortical, and testicular hormones in men infected with human immunodeficiency virus. J Clin Endocrinol Metab. 70:572-577.
37. Rosner W. 1990 The function of corticosteroid binding globulin and sexhormone binding globulin: recent advances. Endocr Rev. 11:80-91.
38. Martin ME, Benassayag C, Amiel C, Canton P, Nunez EA. 1992 Alterations in the concentrations and binding properties of sex steroid binding protein and corticosteroid-binding globulin in HIV+ patients. J Endocrinol Invest. 15:597-603.
39. Griggs RC, Kingston W, Jozefowicz RF, Herr BE, Forbes G, Halliday D. 1989 Effect of testosterone on muscle mass and muscle protein synthesis. J Appl Physiol. 66:498-503.
40. Welle S, Jozefowicz R, Forbes G, Griggs R. 1992 Effect of testosterone on metabolic rate and body composition in normal men and men with muscular dystrophy. J Clin Endocrinol Metab. 74:332-335.
41. Tenover JS. 1992 Effects of testosterone supplementation in the aging male. J Clin Endocrinol Metab. 75:1092-1098.
42. Cameron JL, Weltzin TE, McConaha C, Helmreich DL, Kaye WH. 1991 Slowing of pulsatile luteinizing hormone secretion in men after forty-eight hours fasting. J Clin Endocrinol Metab. 73:35-41.
43. Veldhuis JD, Iranmanesh A, Evans WS, Lizaralde G, Thorner MO, Vance ML. 1993 Amplitude suppression of the pulsatile mode of immunoradiometric leutenizing hormone release in fasting-induced hypoandrogenemia in normal men. J Clin Endocrinol Metab. 76:587-593.
44. Membreno L, Irony I, Dere W, Klein R, Biglieri EG, Cobb E. 1987 Adrenocortical function in acquired immune deficiency syndrome. J Clin Endocrinol Metab. 65:482-487.
45. Leinung MC, Liporace R, Miller CH. 1995 Induction of adrenal suppression by megesterol acetate in patients with AIDS. Ann Intern Med. 122:843-845.
46. Alexieva-Figusch J, Blankenstein MA, De Jong FH, Lamberts WJ. 1984 Endocrine effects of the combination of megesterol acetate and tamoxifen in the treatment of metastatic breast cancer. Eur J Cancer Clin Oncol. 9:1135-1140.
47. De Paepe ME, Waxman M. 1988 Testicular atrophy in AIDS: a study of 57 autopsy cases. Hum Pathol. 20:210-214.
48. Chabon AB, Stenger RJ, Grabstald H. 1987 Histopathology of testis in acquired immune deficiency syndrome. Urology. 29:658-663.
49. Welch K, Finkbeiner W, Alpers CE, et al. 1984 Autopsy findings in the acquired immune deficiency syndrome, J Am Med Wm Assoc. 252: 1152-9.
50. Counts DR, Gwirtsman H, Carlsson LMS, Lesem M, Cutler GB. 1992 The effect of anorexia nervosa and refeeding on growth hormone-binding protein, the insulin-like growth factors (IGFs), and the IGF-binding proteins. J Clin Endocrinol Metab. 75:762-767.
51. Hartman ML, Veldhuis JD, Johnson ML, et al. 1992 Augmented growth hormone (GH) secretory burst frequency and amplitude mediate enhanced GH secretion during a two-day fast in normal men. J Clin Endocrinol Metab. 74:757-765.
52. Jackson Smith W, Underwood LE, Clemmons DR. 1995 Effects of caloric or protein restriction on insulin-like growth factor-1 (IGF-I) and IGF binding proteins in children and adults. J Clin Endocrinol Metab. 80:443-449.
53. Mulligan K, Grunfeld C, Hellerstein MK, Neese RA, Schambelan M. 1993 Anabolic effects of recombinant human growth hormone in patients with wasting associated with human immunodeficiency virus infection. J Clin Endocrinol Metab. 77:956-962.
54. Russell-Jones DL, Weissberger AJ, Bowes SB, et al. 1993 Protein metabolism in growth hormone deficiency, and effects of growth hormone replacement therapy. Acta Endocrinol (Copenh). 2:44-47.